Browsing Tag
Precision Medicine
24 posts
Tempus AI stock soars 14% after FDA approval of xT CDx test
Tempus AI, a leader in healthcare technology, has unveiled its FDA-approved in vitro diagnostic device, xT CDx, marking…
January 15, 2025
QIAGEN invests in new Barcelona facility to expand QIAstat-Dx capabilities
QIAGEN, a leading global provider of molecular diagnostics, has announced a multi-year investment in a new facility in…
November 28, 2024
Tempus AI shakes up precision medicine with $600m acquisition of Ambry Genetics
Tempus AI has taken a significant step in advancing its precision medicine strategy by agreeing to acquire Ambry…
November 5, 2024
Recursion Pharmaceuticals and Exscientia announce merger to transform drug development
Recursion Pharmaceuticals Inc. (Nasdaq: RXRX) and Exscientia plc (Nasdaq: EXAI) have announced a landmark merger, combining their strengths…
August 10, 2024
Tempus and AstraZeneca expand collaboration to enhance cancer care with AI
Tempus, a pioneer in artificial intelligence and precision medicine, has announced an expansion of its collaboration with pharmaceutical…
June 2, 2024
Lantern Pharma announces collaboration with Oregon Therapeutics to advance AI-driven cancer drug development
Lantern Pharma Inc. (NASDAQ: LTRN) announced a strategic collaboration with French biotech company Oregon Therapeutics to enhance the…
May 6, 2024
Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes
Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type…
April 14, 2024
APx Acquisition announces merger with OmnigenicsAI and MultiplAI Health
In a landmark transaction for the biotechnology and AI industries, APx Acquisition Corp. I (NASDAQ: APXI), OmnigenicsAI Corp,…
March 27, 2024
Microsoft and NVIDIA forge ahead with AI and cloud computing in healthcare
Microsoft Corp. is expanding its longstanding partnership with NVIDIA, setting a new benchmark in the integration of generative…
March 19, 2024
Zephyr AI announces $111m Series A to advance AI in precision medicine
Zephyr AI, Inc., a pioneering healthcare technology company committed to enhancing precision medicine through fast and explainable Artificial…
March 14, 2024